Ethyl 3-(4-Fluorophenyl)-3-Oxopropanoate (BioDeep_00000178865)
human metabolite blood metabolite
代谢物信息卡片
Ethyl 3-(4-fluorophenyl)-3-oxopropanoic acid
化学式: C11H11FO3 (210.0692)
中文名称: (4-氟苯甲酰)乙酸乙酯
谱图信息:
最多检出来源 Homo sapiens(blood) 95.74%
分子结构信息
SMILES: CCOC(=O)CC(=O)C1=CC=C(C=C1)F
InChI: InChI=1S/C11H11FO3/c1-2-15-11(14)7-10(13)8-3-5-9(12)6-4-8/h3-6H,2,7H2,1H3
描述信息
同义名列表
数据库引用编号
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- Kazuo Furihata, Mitsuru Tashiro. Development of 1H{19F} saturation transfer difference experiments for detection of a fluorinated compound bound to proteins.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
2022 May; 38(5):825-829. doi:
10.1007/s44211-022-00098-3. [PMID: 35318618] - Yankai Liu, Yajie Wang, Jingming Zhou, Yumei Chen, Hongliang Liu, Yanhua Qi, Luhui Zhao, Yuanyuan Zhang, Aiping Wang. Establishment of an immunological detection method of fleroxacin by fluorescence-linked immunosorbent assay.
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
2021 Apr; 38(4):594-601. doi:
10.1080/19440049.2021.1876251. [PMID: 33667148] - Kazuo Furihata, Mitsuru Tashiro. Identification of Binding Epitopes of a Fluorinated Compound Bound to Proteins Using 1H and 19F NMR Spectroscopy.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
2020 Jul; 36(7):881-883. doi:
10.2116/analsci.19n033. [PMID: 32037346] - Kai Li, Zhongling Liu, Yue Liu, Hanqi Zhang, Wei Yu. Collection and Separation of Fleroxacin and Ciprofloxacin in Ultrasound-Assisted Ionic Liquid Salting-Out Microextraction System.
Journal of chromatographic science.
2020 Jun; 58(6):576-584. doi:
10.1093/chromsci/bmaa021. [PMID: 32448888] - Tian-Yu Liu, Xiang-Long Qu, Bing Yan. A highly sensitive and selective 'turn-on' fluorescent probe for detection of fleroxacin in human serum and urine based on a lanthanide functionalized metal-organic framework.
Dalton transactions (Cambridge, England : 2003).
2019 Dec; 48(48):17945-17952. doi:
10.1039/c9dt03830b. [PMID: 31793573] - Yuanyuan Jiao, Tae Hwan Kim, Xun Tao, Martina Kinzig, Cornelia B Landersdorfer, Stefanie K Drescher, Dhruvitkumar S Sutaria, Bartolome Moya, Ulrike Holzgrabe, Fritz Sörgel, Jürgen B Bulitta. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
2018 Oct; 123(?):416-428. doi:
10.1016/j.ejps.2018.07.054. [PMID: 30076955] - Cheng-yu Dong, Jia Xu, Shan-shan Zhou, Ying Liu. Spectroscopic and Molecular Modeling Studies on Binding of Fleroxacin with Human Serum Albumin.
Guang pu xue yu guang pu fen xi = Guang pu.
2017 Jan; 37(1):327-32. doi:
NULL. [PMID: 30222301] - Ying Xiao, Qing Wang, Yanmei Huang, Xiangling Ma, Xinnuo Xiong, Hui Li. Synthesis, structure, and biological evaluation of a copper(ii) complex with fleroxacin and 1,10-phenanthroline.
Dalton transactions (Cambridge, England : 2003).
2016 Jul; 45(27):10928-35. doi:
10.1039/c6dt00915h. [PMID: 27301999] - Hanwen Sun, Liqing Li, Yuanyuan Wu. Capillary electrophoresis with electrochemiluminescence detection for simultaneous determination of proline and fleroxacin in human urine.
Drug testing and analysis.
2009 Feb; 1(2):87-92. doi:
10.1002/dta.22. [PMID: 20355181] - Jahye Kim, Hisakazu Ohtani, Masayuki Tsujimoto, Yasufumi Sawada. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Drug metabolism and pharmacokinetics.
2009; 24(2):167-74. doi:
10.2133/dmpk.24.167. [PMID: 19430173] - Gen-Hua Wu, Jie Wang, Chang Guo, Dong-Xiang Wang, Ting-Ting Zhao. [Study on the ternary complex of FLRX, zinc(II) and BSA by the method of fluorescence].
Guang pu xue yu guang pu fen xi = Guang pu.
2007 Apr; 27(4):765-8. doi:
NULL. [PMID: 17608194] - Myo-Kyoung Kim, Charles Nightingale, David Nicolau. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
Clinical pharmacokinetics.
2003; 42(11):985-96. doi:
10.2165/00003088-200342110-00004. [PMID: 12908854] - Tomoko Yazaki, Yuji Yoshiyama, Paul Wong, Denis Beauchamp, Motoko Kanke. Protective effect of fleroxacin against the nephrotoxicity of isepamicin in rats.
Biological & pharmaceutical bulletin.
2002 Apr; 25(4):516-9. doi:
10.1248/bpb.25.516. [PMID: 11995935] - R Thiel, S Metzner, C Gericke, U Rahm, R Stahlmann. Effects of fluoroquinolones on the locomotor activity in rats.
Archives of toxicology.
2001 Mar; 75(1):36-41. doi:
10.1007/s002040000207. [PMID: 11357519] - M Rizk, F Belal, F Ibrahim, S Ahmed, N M El-Enany. Voltammetric analysis of certain 4-quinolones in pharmaceuticals and biological fluids.
Journal of pharmaceutical and biomedical analysis.
2000 Dec; 24(2):211-8. doi:
10.1016/s0731-7085(00)00401-5. [PMID: 11130200] - E C de Lange, S Marchand, D van den Berg, I C van der Sandt, A G de Boer, A Delon, S Bouquet, W Couet. In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
2000 Dec; 12(2):85-93. doi:
10.1016/s0928-0987(00)00149-4. [PMID: 11102735] - C M Chukwuani, H A Coker, A M Oduola, A Sowunmi, N D Ifudu. Bioavailability of ciprofloxacin and fleroxacin: results of a preliminary investigation in healthy adult Nigerian male volunteers.
Biological & pharmaceutical bulletin.
2000 Aug; 23(8):968-72. doi:
10.1248/bpb.23.968. [PMID: 10963305] - E J Begg, R A Robson, D A Saunders, G G Graham, R C Buttimore, A M Neill, G I Town. The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing.
British journal of clinical pharmacology.
2000 Jan; 49(1):32-8. doi:
10.1046/j.1365-2125.2000.00105.x. [PMID: 10606835] - M Zhao, S Jiang, R Wang. [The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
Zhonghua nei ke za zhi.
1999 Feb; 38(2):98-100. doi:
NULL. [PMID: 11798634] - C M Chukwuani, H A Coker, A M Oduola, N D Ifudu, A Sowunmi. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers.
Chemotherapy.
1998 Nov; 44(6):369-76. doi:
10.1159/000007146. [PMID: 9755295] - E Rey, J M Tréluyer, G Pons. Drug disposition in cystic fibrosis.
Clinical pharmacokinetics.
1998 Oct; 35(4):313-29. doi:
10.2165/00003088-199835040-00004. [PMID: 9812180] - M Jelikic-Stankov, J Odovic, D Stankov, P Djurdjevic. Determination of fleroxacin in human serum and in dosage forms by derivative UV spectrophotometry.
Journal of pharmaceutical and biomedical analysis.
1998 Oct; 18(1-2):145-50. doi:
10.1016/s0731-7085(98)00151-4. [PMID: 9863952] - M Kimura, J Fujiyama, A Nagai, M Hirayama, M Kuriyama. [Encephalopathy induced by fleroxacin in a patient with Machado-Joseph disease].
Rinsho shinkeigaku = Clinical neurology.
1998 Sep; 38(9):846-8. doi:
. [PMID: 10078039] - M Tsugawa, K Monden, Y Nasu, H Kumon, H Ohmori. Prospective randomized comparative study of antibiotic prophylaxis in urethrocystoscopy and urethrocystography.
International journal of urology : official journal of the Japanese Urological Association.
1998 Sep; 5(5):441-3. doi:
10.1111/j.1442-2042.1998.tb00384.x. [PMID: 9781431] - K G Naber, U Theuretzbacher, M Kinzig, O Savov, F Sörgel. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
Antimicrobial agents and chemotherapy.
1998 Jul; 42(7):1659-65. doi:
10.1128/aac.42.7.1659. [PMID: 9661000] - C Förster, M Rücker, M Shakibaei, I Baumann-Wilschke, J Vormann, R Stahlmann. Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
Archives of toxicology.
1998 Jun; 72(7):411-9. doi:
10.1007/s002040050521. [PMID: 9708880] - K G Naber, M Well, K Hollauer, D Kirchbauer, W Witte. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
Chemotherapy.
1998 Mar; 44(2):77-84. doi:
10.1159/000007096. [PMID: 9551236] - J Viitanen, K Malminiemi, J Kallio, V M Puolakka, P Rajala, T L Tammela. Transurethral prostatectomy in patients with preoperative bacteriuria: double-blind study with oral fleroxacin and cefalexin.
Chemotherapy.
1998 Jan; 44(1):69-75. doi:
10.1159/000007093. [PMID: 9444412] - N Hobara, H Kameya, N Hokama, S Ohshiro, M Sakanashi. Rapid and simple determination of fleroxacin in rat plasma using a solid-phase extraction column.
Journal of chromatography. B, Biomedical sciences and applications.
1997 Dec; 703(1-2):279-83. doi:
10.1016/s0378-4347(97)00409-x. [PMID: 9448088] - T Deguchi, M Yasuda, M Nakano, S Ozeki, E Kanematsu, H Fukuda, S Maeda, I Saito, Y Kawada. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Chemotherapy.
1997 Jul; 43(4):239-44. doi:
10.1159/000239573. [PMID: 9209780] - D Beauchamp, G Laurent, L Grenier, P Gourde, J Zanen, J A Heuson-Stiennon, M G Bergeron. Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin.
Antimicrobial agents and chemotherapy.
1997 Jun; 41(6):1237-45. doi:
10.1128/aac.41.6.1237. [PMID: 9174177] - G Klecak, F Urbach, H Urwyler. Fluoroquinolone antibacterials enhance UVA-induced skin tumors.
Journal of photochemistry and photobiology. B, Biology.
1997 Feb; 37(3):174-81. doi:
10.1016/s1011-1344(96)07424-6. [PMID: 9085564] - C Förster, R Schwabe, E Lozo, U Zippel, J Vormann, T Günther, H J Merker, R Stahlmann. Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.
Archives of toxicology.
1997; 72(1):26-32. doi:
10.1007/s002040050464. [PMID: 9458187] - M Müller, O Haag, T Burgdorff, A Georgopoulos, W Weninger, B Jansen, G Stanek, H Pehamberger, E Agneter, H G Eichler. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans.
Antimicrobial agents and chemotherapy.
1996 Dec; 40(12):2703-9. doi:
10.1128/aac.40.12.2703. [PMID: 9124826] - F Fuentes, M M Martín, J Izquierdo, M L Gomez-Lus, J Prieto. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
Chemotherapy.
1996 Sep; 42(5):354-62. doi:
10.1159/000239467. [PMID: 8874975] - D E Uehlinger, F Schaedeli, M Kinzig, F Sörgel, F J Frey. Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.
Antimicrobial agents and chemotherapy.
1996 Aug; 40(8):1903-9. doi:
10.1128/aac.40.8.1903. [PMID: 8843301] - T C Gasser, M Wisard, R Frei. Oral fleroxacin prophylaxis in transurethral surgery.
The Journal of urology.
1996 Jul; 156(1):146-8. doi:
. [PMID: 8648777] - J C Hall, K J Christiansen, P England, A I Low, P J McRae, J Mander, T A Taylor, J L Hall. Antibiotic prophylaxis for patients undergoing transurethral resection of the prostate.
Urology.
1996 Jun; 47(6):852-6. doi:
10.1016/s0090-4295(96)00066-0. [PMID: 8677576] - T Ooie, H Suzuki, T Terasaki, Y Sugiyama. Characterization of the transport properties of a quinolone antibiotic, fleroxacin, in rat choroid plexus.
Pharmaceutical research.
1996 Apr; 13(4):523-7. doi:
10.1023/a:1016081618149. [PMID: 8710740] - H Giamarellou. Fleroxacin in complicated urinary tract infections.
Chemotherapy.
1996 Mar; 42 Suppl 1(?):17-27. doi:
10.1159/000239488. [PMID: 8861531] - K G Naber. Fleroxacin overview.
Chemotherapy.
1996 Mar; 42 Suppl 1(?):1-9. doi:
10.1159/000239485. [PMID: 8861529] - C E Edmiston, E C Suarez, A P Walker, M P Demeure, C T Frantzides, W J Schulte, S D Wilson. Penetration of ciprofloxacin and fleroxacin into biliary tract.
Antimicrobial agents and chemotherapy.
1996 Mar; 40(3):787-91. doi:
10.1128/aac.40.3.787. [PMID: 8851613] - T Yamamoto, H Kusajima, M Hosaka, H Shinoda. Uptake and intracellular activity of fleroxacin in phagocytic cells.
Chemotherapy.
1995 Sep; 41(5):353-9. doi:
10.1159/000239367. [PMID: 8521737] - H Sagara, I Tomizawa, Y Takizawa, Y Nitta, T Tsunoda, T Yamaguchi, G Masuda, M Negishi, A Ajisawa, M Murata. [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.
1994 Nov; 68(11):1390-408. doi:
10.11150/kansenshogakuzasshi1970.68.1390. [PMID: 7829908] - J Schrenzel, F Cerruti, M Herrmann, T Leemann, E Weidekamm, R Portmann, B Hirschel, D P Lew. Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
Antimicrobial agents and chemotherapy.
1994 Jun; 38(6):1219-24. doi:
10.1128/aac.38.6.1219. [PMID: 8092817] - A Pefanis, C Thauvin-Eliopoulos, J Holden, G M Eliopoulos, M J Ferraro, R C Moellering. Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses.
Antimicrobial agents and chemotherapy.
1994 Feb; 38(2):252-5. doi:
10.1128/aac.38.2.252. [PMID: 8192453] - A J Szuna, R W Blain. Determination of a new antibacterial agent (Ro 23-9424) by multidimensional high-performance liquid chromatography with ultraviolet detection and direct plasma injection.
Journal of chromatography.
1993 Oct; 620(2):211-6. doi:
10.1016/0378-4347(93)80006-p. [PMID: 8300788] - J Schrenzel, P Dayer, T Leemann, E Weidekamm, R Portmann, D P Lew. Influence of rifampin on fleroxacin pharmacokinetics.
Antimicrobial agents and chemotherapy.
1993 Oct; 37(10):2132-8. doi:
10.1128/aac.37.10.2132. [PMID: 8257135] - A J Fischman, E Livni, J Babich, N M Alpert, Y Y Liu, E Thom, R Cleeland, B L Prosser, J A Correia, H W Strauss. Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.
Antimicrobial agents and chemotherapy.
1993 Oct; 37(10):2144-52. doi:
10.1128/aac.37.10.2144. [PMID: 8257137] - H Hummler, W F Richter, A G Hendrickx. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
Toxicology and applied pharmacology.
1993 Sep; 122(1):34-45. doi:
10.1006/taap.1993.1169. [PMID: 8397453] - J Guinea, M Robert, D Gargallo-Viola, M A Xicota, J Garcia, E Tudela, M Esteve, R Coll, M Pares, R Roser. In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent.
Antimicrobial agents and chemotherapy.
1993 Apr; 37(4):868-74. doi:
10.1128/aac.37.4.868. [PMID: 8388202] - C E Cox. Comparison of intravenous fleroxacin with ceftazidime for treatment of complicated urinary tract infections.
The American journal of medicine.
1993 Mar; 94(3A):118S-125S. doi:
. [PMID: 8452167] - E Weidekamm. Pharmacokinetics of fleroxacin in renal impairment.
The American journal of medicine.
1993 Mar; 94(3A):70S-74S. doi:
. [PMID: 8452185] - E Weidekamm, R Portmann. Penetration of fleroxacin into body tissues and fluids.
The American journal of medicine.
1993 Mar; 94(3A):75S-80S. doi:
NULL. [PMID: 8452186] - C H Nightingale. Overview of the pharmacokinetics of fleroxacin.
The American journal of medicine.
1993 Mar; 94(3A):38S-43S. doi:
10.1016/s0002-9343(20)31138-4. [PMID: 8452184] - W Ulmer. Fleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis.
The American journal of medicine.
1993 Mar; 94(3A):136S-141S. doi:
10.1016/s0002-9343(20)31154-2. [PMID: 8452170] - D W Morck, M E Olson, S G McKay, K Lam, B Prosser, R Cleeland, J W Costerton. Therapeutic efficacy of fleroxacin for eliminating catheter-associated urinary tract infection in a rabbit model.
The American journal of medicine.
1993 Mar; 94(3A):23S-30S. doi:
NULL. [PMID: 8452182] - M Dan, E Weidekamm, R Sagiv, R Portmann, H Zakut. Penetration of fleroxacin into breast milk and pharmacokinetics in lactating women.
Antimicrobial agents and chemotherapy.
1993 Feb; 37(2):293-6. doi:
10.1128/aac.37.2.293. [PMID: 8452360] - G L Kearns. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
The Annals of pharmacotherapy.
1993 Jan; 27(1):74-9. doi:
10.1177/106002809302700117. [PMID: 8431626] - T J Lubowski, C H Nightingale, K Sweeney, R Quintiliani. Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers.
Antimicrobial agents and chemotherapy.
1992 Dec; 36(12):2758-60. doi:
10.1128/aac.36.12.2758. [PMID: 1482143] - P H Edelstein, M A Edelstein, B Holzknecht. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Antimicrobial agents and chemotherapy.
1992 Nov; 36(11):2387-91. doi:
10.1128/aac.36.11.2387. [PMID: 1489182] - A J Fischman, E Livni, J Babich, N M Alpert, Y Y Liu, E Thom, R Cleeland, B L Prosser, R J Callahan, J A Correia. Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography.
Antimicrobial agents and chemotherapy.
1992 Oct; 36(10):2286-92. doi:
10.1128/aac.36.10.2286. [PMID: 1444310] - R A Blouin, B A Hamelin, D A Smith, T S Foster, W J John, H A Welker. Fleroxacin pharmacokinetics in patients with liver cirrhosis.
Antimicrobial agents and chemotherapy.
1992 Mar; 36(3):632-8. doi:
10.1128/aac.36.3.632. [PMID: 1622175] - T J Lubowski, C Nightingale, K Sweeney, R Quintiliani, J Zhi. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
Antimicrobial agents and chemotherapy.
1992 Mar; 36(3):651-5. doi:
10.1128/aac.36.3.651. [PMID: 1622179] - A E Stuck, D K Kim, F J Frey. Fleroxacin clinical pharmacokinetics.
Clinical pharmacokinetics.
1992 Feb; 22(2):116-31. doi:
10.2165/00003088-199222020-00003. [PMID: 1551289] - A Georgopoulos, S M Feistauer, W Graninger, S Pfleger, M Georgopoulos. Antibacterial activity of sparfloxacin against experimental renal infections in mice.
Antimicrobial agents and chemotherapy.
1992 Feb; 36(2):505-7. doi:
10.1128/aac.36.2.505. [PMID: 1318685] - R Portmann, E Weidekamm. Penetration of fleroxacin into human and animal tissues.
Chemotherapy.
1992; 38(3):145-9. doi:
10.1159/000238954. [PMID: 1511632] - M Cakmakci, L Gossweiler, J Schilling, R Schlumpf, S Geroulanos. Penetration of fleroxacin into human lung, muscle, and fat tissue.
Drugs under experimental and clinical research.
1992; 18(7):299-302. doi:
NULL. [PMID: 1295723] - M H Miller, A Madu, G Samathanam, D Rush, C N Madu, K Mathisson, M Mayers. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits.
Antimicrobial agents and chemotherapy.
1992 Jan; 36(1):32-8. doi:
10.1128/aac.36.1.32. [PMID: 1590696] - N Keller, G Raponi, I M Hoepelman, B P Overbeek, M Rozenberg-Arska, J Verhoef. Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.
Zentralblatt fur Bakteriologie : international journal of medical microbiology.
1991 Jan; 274(4):519-26. doi:
10.1016/s0934-8840(11)80090-3. [PMID: 1907453] - W L Hayton, V Vlahov, N Bacracheva, I Viachki, R Portmann, G Muirhead, K Stoeckel, E Weidekamm. Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients.
Antimicrobial agents and chemotherapy.
1990 Dec; 34(12):2375-80. doi:
10.1128/aac.34.12.2375. [PMID: 2128442] - P Jynge, T Skjetne, I Gribbestad, C H Kleinbloesem, H F Hoogkamer, O Antonsen, J Krane, O E Bakøy, K M Furuheim, O G Nilsen. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans.
Clinical pharmacology and therapeutics.
1990 Nov; 48(5):481-9. doi:
10.1038/clpt.1990.183. [PMID: 2121409] - J C Akaniro, C E Vidaurre, H R Stutman, M I Marks. Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.
Antimicrobial agents and chemotherapy.
1990 Oct; 34(10):1880-4. doi:
10.1128/aac.34.10.1880. [PMID: 2127170] - J G Christenson, K K Chan, R Cleeland, B Dix-Holzknecht, H H Farrish, I H Patel, A Specian. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
Antimicrobial agents and chemotherapy.
1990 Oct; 34(10):1895-900. doi:
10.1128/aac.34.10.1895. [PMID: 2127171] - J P Fillastre, A Leroy, B Moulin, M Dhib, F Borsa-Lebas, G Humbert. Pharmacokinetics of quinolones in renal insufficiency.
The Journal of antimicrobial chemotherapy.
1990 Oct; 26 Suppl B(?):51-60. doi:
10.1093/jac/26.suppl_b.51. [PMID: 2124213] - H Lode, G Höffken, M Boeckk, N Deppermann, K Borner, P Koeppe. Quinolone pharmacokinetics and metabolism.
The Journal of antimicrobial chemotherapy.
1990 Oct; 26 Suppl B(?):41-9. doi:
10.1093/jac/26.suppl_b.41. [PMID: 2124212] - F Taga, F Kobayashi, S Saito, T Ooie, F Kawahara, H Uchida, J Shimada, S Hori, O Sakai. Possibility for induction of convulsion by fleroxacin and its disposition in the central nervous system in animals.
Arzneimittel-Forschung.
1990 Aug; 40(8):900-4. doi:
. [PMID: 2173611] - A M Taburet, A Devillers, P Thomare, J P Fillastre, P Veyssier, E Singlas. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.
Clinical pharmacokinetics.
1990 Jul; 19(1):80-8. doi:
10.2165/00003088-199019010-00006. [PMID: 2116257] - E Singlas, A Leroy, E Sultan, M Godin, B Moulin, A M Taburet, M Dhib, J P Fillastre. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.
Clinical pharmacokinetics.
1990 Jul; 19(1):67-79. doi:
10.2165/00003088-199019010-00005. [PMID: 2116256] - M Parent, M St-Laurent, M LeBel. Safety of fleroxacin coadministered with theophylline to young and elderly volunteers.
Antimicrobial agents and chemotherapy.
1990 Jun; 34(6):1249-53. doi:
10.1128/aac.34.6.1249. [PMID: 2118328] - J Mimeault, F Vallée, R Seelmann, F Sörgel, M Ruel, M LeBel. Altered disposition of fleroxacin in patients with cystic fibrosis.
Clinical pharmacology and therapeutics.
1990 May; 47(5):618-28. doi:
10.1038/clpt.1990.83. [PMID: 2111750] - K Heim-Duthoy, G Peltier, W Awni. Steady-state pharmacokinetics of fleroxacin in patients with skin and skin structure infections.
Antimicrobial agents and chemotherapy.
1990 May; 34(5):922-3. doi:
10.1128/aac.34.5.922. [PMID: 2113797] - P Heizmann, D Dell, H Eggers, R Gora. Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection.
Journal of chromatography.
1990 Apr; 527(1):91-101. doi:
10.1016/s0378-4347(00)82086-1. [PMID: 2114419] - E Brunt, J Limberg, H Derendorf. High-performance liquid chromatographic assay and erythrocyte partitioning of fleroxacin, a new fluoroquinolone antibiotic.
Journal of pharmaceutical and biomedical analysis.
1990; 8(1):67-71. doi:
10.1016/0731-7085(90)80008-d. [PMID: 2129330] - K Shiba, A Saito, J Shimada, S Hori, M Kaji, T Miyahara, H Kusajima, S Kaneko, S Saito, T Ooie. Renal handling of fleroxacin in rabbits, dogs, and humans.
Antimicrobial agents and chemotherapy.
1990 Jan; 34(1):58-64. doi:
10.1128/aac.34.1.58. [PMID: 2109576] - E Leibovitz, G Keren, M Shabtai, A Barzilai, E Rubinstein. The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
The Journal of antimicrobial chemotherapy.
1989 Sep; 24(3):375-85. doi:
10.1093/jac/24.3.375. [PMID: 2509411] - C Koechlin, F Jehl, L Linger, H Monteil. High-performance liquid chromatography for the determination of three new fluoroquinolones, fleroxacin, temafloxacin and A-64730, in biological fluids.
Journal of chromatography.
1989 Jul; 491(2):379-87. doi:
10.1016/s0378-4347(00)82855-8. [PMID: 2509509] - D Gür, G Hasçelik, Y Akyön, H E Akalin, S Diker. [In vitro susceptibility of Campylobacter jejuni and Campylobacter coli to quinolone antibiotics].
Mikrobiyoloji bulteni.
1989 Jul; 23(3):185-9. doi:
NULL. [PMID: 2518646] - D Höffler, P Koeppe, R Metz, M Pech, F Sörgel. Fleroxacin pharmacokinetics in healthy volunteers and impaired renal function.
Journal of chemotherapy (Florence, Italy).
1989 Jul; 1(4 Suppl):558-60. doi:
NULL. [PMID: 16312531] - A E Stuck, F J Frey, P Heizmann, R Brandt, E Weidekamm. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
Antimicrobial agents and chemotherapy.
1989 Mar; 33(3):373-81. doi:
10.1128/aac.33.3.373. [PMID: 2499248] - R G Tudor, D J Youngs, K Yoshioka, D W Burdon, M R Keighley. A comparison of the penetration of two quinolones into intra-abdominal abscess.
Archives of surgery (Chicago, Ill. : 1960).
1988 Dec; 123(12):1487-90. doi:
10.1001/archsurg.1988.01400360057008. [PMID: 3142444] - W M Awni, J A Maloney, K L Heim-Duthoy. Liquid-chromatographic determination of fleroxacin in serum and urine.
Clinical chemistry.
1988 Nov; 34(11):2330-2. doi:
10.1093/clinchem/34.11.2330. [PMID: 3141086] - Y Oomori, T Yasue, H Aoyama, K Hirai, S Suzue, T Yokota. Effects of fleroxacin on HeLa cell functions and topoisomerase II.
The Journal of antimicrobial chemotherapy.
1988 Oct; 22 Suppl D(?):91-7. doi:
10.1093/jac/22.supplement_d.91. [PMID: 2849603] - W Ritzerfeld. Comparative studies of fleroxacin and ofloxacin in experimental pyelonephritis.
The Journal of antimicrobial chemotherapy.
1988 Oct; 22 Suppl D(?):119-22. doi:
10.1093/jac/22.supplement_d.119. [PMID: 3144529] - D J Youngs, R G Tudor, K Yoshioka, M R Keighley. The penetration of fleroxacin into intra-abdominal abscesses.
The Journal of antimicrobial chemotherapy.
1988 Oct; 22 Suppl D(?):115-8. doi:
10.1093/jac/22.supplement_d.115. [PMID: 3144528] - A W Mondorf, A Buch, G Steinbacher, C Rüdel, F W Falkenberg. Renal tolerance of fleroxacin in healthy volunteers.
The Journal of antimicrobial chemotherapy.
1988 Oct; 22 Suppl D(?):179-89. doi:
10.1093/jac/22.supplement_d.179. [PMID: 2904925] - K G Naber, F Sörgel, F Kees, H Schumacher, R Metz, H Grobecker. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
The Journal of antimicrobial chemotherapy.
1988 Oct; 22 Suppl D(?):199-207. doi:
10.1093/jac/22.supplement_d.199. [PMID: 2462556] - F Sörgel, R Seelmann, K Naber, R Metz, P Muth. Metabolism of fleroxacin in man.
The Journal of antimicrobial chemotherapy.
1988 Oct; 22 Suppl D(?):169-78. doi:
10.1093/jac/22.supplement_d.169. [PMID: 3144535] - A C Panneton, M G Bergeron, M LeBel. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
Antimicrobial agents and chemotherapy.
1988 Oct; 32(10):1515-20. doi:
10.1128/aac.32.10.1515. [PMID: 3142338]
